Search
vestibular schwannoma (acoustic neuroma)
schwannoma or neurilemmoma of 8th nerve; acoustic neuroma is misnomer.
Etiology:
- idiopathic sporadic unilateral 95%
- cancer susceptibility syndromes
- neurofibromatosis type 2
- schwannomatosis
Epidemiology:
- 8% of all intracranial neoplasms
- lifetime prevalence of 1 in 500 persons
- increasing incidence due to enhanced detection
- most common in 6th or 7th decade in life
- 20 cases per 100,000 person years [8]
Pathology:
1) arise from myelinating Schwann cells of vestibular division of cranial nerve VIII [8]
2) compressive growth with the internal auditory canal/meatus results in unilateral tinnitus & hearing loss
3) compromise of cranial nerves VII & VIII, the brain stem & the cerebellum may occur
Clinical manifestations:
1) sensorineural hearing loss
a) tinnitus &/or vertigo may be presenting symptoms
b) hearing loss is usually unilateral (90%) [3,8]
c) Weber test lateralizes to the unaffected ear
2) symptoms are generally progressive rather than episodic
3) symptoms are often unilateral
4) vestibular symptoms (unsteadiness, balance issues)
5) acoustic & vestibular symptoms are not reliable indicators of tumor growth [8]
6) cranial nerves 5, 7, 9, 10, 11 may be affected with tumor progression [2]
7) even large schwannomas generally do not affect facial-nerve, trigeminal motor, or lower cranial-nerve dysfunction [8]
8) abnormal finger to nose test suggests compression of cerebellum
Special laboratory:
- audiometry 6 months after diagnostic MRI, then annually
- confirmatory biopsy rarely needed [8]
Radiology:
- magnetic resonance imaging (MRI) of the posterior fossa & internal auditory canal with gadolinium contrast
- yield of MRI for vestibular schwannoma diagnosis < 3% [7]
- once diagnosed, serial imaging should be obtained at annually, regardless of symptoms [8]
Differential diagnosis:
- facial-nerve schwannoma
- meningioma
- malignant peripheral-nerve sheath tumors
- metastases from primary tumors at other sites
- otosclerosis: associated with conductive hearing loss*
- cholesteoma: associated with conductive hearing loss*
* Weber test lateralizes to affected ear
Complications:
- compression of cochlear nerve or labyrinthine artery
- impaired circulation of CSF
- inflammation mediated by schwannoma
- as the tumor enlarges, it compresses cranial nerves & the cerebellum [3]
Management:
- referral to otorhinolaryngologist
- stereotactic radiosurgery - gamma-knife radiosurgery
- maximal neoplasm diameter < 3.0 cm in the cerebellopontine angle
- complications include: brain-stem edema, trigeminal neuralgia, hydrocephalus [8]
- upfront radiosurgery for small & medium size tumors results in greater tumor reduction at 4 years than treatment with tumor growth [10]
- microsurgical resection
- treatment of choice for large neoplasm associated with:
- symptomatic brain-stem compression, hydrocephalus, trigeminal neuralgia [8]
- general anesthesia, operating microscope, intraoperative neural monitoring
- sensorineural hearing loss & vestibular dysfunction are not reversed with treatment [8]
- conservative management
- prioritizing preservation of neurologic function vs cure
- potential for overtreatment resulting in unnecessary complications & health care expenses
- untreated vestibular schwannoma in patients >= 70 years not associated with shorter lifespan [11]
- investigational drug treatment includes aspirin & monoclonal antibodies
- no strong evidence any treatment is superior to others
- some patients may require rehabilitation
General
benign cranial nerve neoplasm
neuroma
schwannoma (neurilemoma, neurinoma)
References
- UCLA Intensive Course in Geriatric Medicine & Board Review,
Marina Del Ray, CA, Sept 12-15, 2001
- UpToDate 14.1
http://www.utdol.com
- Geriatric Review Syllabus, 7th edition
Parada JT et al (eds)
American Geriatrics Society, 2010
- Geriatric Review Syllabus, 11th edition (GRS11)
Harper GM, Lyons WL, Potter JF (eds)
American Geriatrics Society, 2022
- McDonald R
Acoustic neuroma: what the evidence says about evaluation
and treatment.
J Fam Pract. 2011 Jun;60(6):E1-4.
PMID: 21647465
- deprecated reference
- Acoustic Neuroma. NIH Consensus Statement Online 1991
Dec 11-13;9(4):1-24
http://consensus.nih.gov/cons/087/087_statement.htm
- Dunn IF, Bi WL, Mukundan S et al.
Congress of Neurological Surgeons Systematic Review and
Evidence-Based Guidelines on the Role of Imaging in the
Diagnosis and Management of Patients With Vestibular Schwannomas.
Neurosurgery. 2018 Feb 1;82(2)E32-34.
PMID: 29309686
https://academic.oup.com/neurosurgery/article/82/2/E32/4764045
- Sweeney AD, Carlson ML, Shepard, NT.
Congress of Neurological Surgeons Systematic Review and
Evidence-Based Guideline on Otologic and Audiologic Screening
for Patients With Vestibular Schwannomas. Congress of
Neurological Surgeons. 2017.
Neurosurgery. 2018 Feb 1;82(2):E29-E31.
PMID: 29309699
https://www.cns.org/guidelines/guidelines-management-patients-vestibular-schwannoma/chapter_2
- Carlson ML, Link MJ
Vestibular Schwannomas.
N Engl J Med 2021; 384:1335-1348. April 8.
PMID: 33826821
https://www.nejm.org/doi/full/10.1056/NEJMra2020394
- Gupta VK, Thakker A, Gupta KK.
Vestibular schwannoma: what we know and where we are heading.
Head Neck Pathol. 2020;14(4):1058-1066
PMID: 32232723 PMCID: PMC7669921 Free PMC article
https://link.springer.com/article/10.1007/s12105-020-01155-x
- Dhayalan D, Tveiten OV, Finnkirk M et al
Upfront Radiosurgery vs a Wait-and-Scan Approach for Small- or Medium-Sized
Vestibular Schwannoma. The V-REX Randomized Clinical Trial.
JAMA. 2023;330(5):421-431.
PMID: 37526718 PMCID: PMC10394573 Free PMC article
https://jamanetwork.com/journals/jama/fullarticle/2807745
- Mistarz N, Reznitsky M, Hostmark K et al
Life Expectancy After Diagnosis of a Vestibular Schwannoma in Patients 70 Years
and Older.
JAMA Otolaryngol Head Neck Surg. 2023 Oct 26.
PMID: 37883070
https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2811314
- Vestibular Schwannoma (Acoustic Neuroma) and Neurofibromatosis
[NIDCD Health Information]
http://www.nidcd.nih.gov/health/hearing/acoustic_neuroma.asp